ˌɔn mˈeɪ nˈaɪn, tˈuː θˈaʊzənd nˈaɪn, ˈæftɚ bˌiːɪŋ ɪnfˈɔːɹmd baɪ ðɪ ˌɛfdˌiːˈeɪ ðə pɹˈɑːdʌkts ɹˈɪsks aʊtwˈeɪd ðə bˈɛnɪfˌɪts, ðə kˈʌmpəni ʃˈʌt dˌaʊn ˌɑːpɚɹˈeɪʃənz.
On May 9, 2009, after being informed by the FDA the product's risks outweighed the benefits, the company shut down operations.